EternoGen is a medical Bio-Tech company with a focus on designing and manufacturing a novel collagen scaffold for soft tissue therapeutic applications. EternoGen is primarily a research and development company that utilizes expertise in clinical market evaluation, material science, and biological engineering to execute its clinical development model.
EternoGens works with the mission to offer a collagen based replenishment therapy for aesthetic enhancement to the global market. EternoGens productline will be recognised as the preferred regenerative brand for soft tissue augmentation, also providing skin strength. EternoGens injectable collagen matrix act as unique next generations dermal filler with a duration for up to two years, thanks to the core patent useing gold nanoparticles . The worldwide market for dermal fillers is worth 2 billion dollars with an annual growth of 12-15 %.
Company Details
- Address
- 1601 S. Providence Rd Suite 119, Columbia,missouri 65211,united States
- Phone
- (501) 339-7962
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- eternogen.com
- Keywords
- Bio-Technology, Nanotechnology, Collagen.
- HQ
- Columbia, Missouri
Eternogen Questions
Eternogen's helpline number is (501) 339-7962
Eternogen's website is eternogen.com
Eternogen's LinkedIn profile is https://www.linkedin.com/company/eternogen-llc
Eternogen's industry is
Biotechnology Research
Eternogen's top competitors are
Speximo Ab,
Medwell Technologies,
Pharmalex,
Akira Aesthetic Ab,
M Dialysis Ab,
Shewy,
Qima Life Sciences,
Oxagon Ab,
Sue Ellen Investments,
Truelastin, Inc..
Eternogen's categories are Biotechnology Research
